Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Nina H. Bjarnason"'
Publikováno v:
Journal of Smoking Cessation. 5:15-21
To study beliefs about smoking and COPD, and motivation for smoking discontinuation we recruited 100 COPD patients during admission for exacerbation. They were asked about motivation to quit smoking and about disease understanding. We compared their
Autor:
Nina H Bjarnason, Mads J. Andersen, Peter Oturai, M. Zemtsovski, Mads Hornum, Michael Perch, Pia Jensen, Karl Bang Christensen, Martin Iversen, Christian H. Møller, Jørn Carlsen, Bo Feldt-Rasmussen
Publikováno v:
Nephrology Dialysis Transplantation. 33:i111-i111
Autor:
Inger Byrjalsen, Claus Christiansen, Peter Alexandersen, Thure Krarup, Nina H. Bjarnason, Jens J. Holst, Dennis Bang Henriksen, Tina Vilsbøll, Eva E G Henriksen, Bolette Hartmann
Publikováno v:
Journal of Bone and Mineral Research. 18:2180-2189
Collagen type I fragments, reflecting bone resorption, and release of gut hormones were investigated after a meal. Investigations led to a dose escalation study with glucagon like peptide-2 (GLP-2) in postmenopausal women. We found a dose-dependent e
Autor:
Nina H. Bjarnason
Publikováno v:
New England Journal of Medicine. 349:2068-2071
Autor:
Nina H Bjarnason
Publikováno v:
International Congress Series. 1229:69-77
Osteoporosis is a serious and frequently occurring disease. Sensitive, specific and precise biochemical markers of bone turnover have, thus, the potential of being the important tools in the evaluation of bone loss, fracture risk and response to inte
Autor:
Christian H. Møller, Mads Hornum, Michael Perch, Pia Bredahl, Jørn Carlsen, Nina H Bjarnason, Mads J. Andersen, Martin Iversen, Peter Oturai, Bo Feldt-Rasmussen, Karl O. Christiansen, M. Zemtsovski
Publikováno v:
Nephrology Dialysis Transplantation. 32:iii27-iii27
Autor:
Desmond E. Thompson, Giovanni Cizza, Nina H. Bjarnason, Pernille Ravn, Michael R. McClung, C. Christiansen, R. D. Wasnich, A. J. Yates, David J. Hosking, M. Daley
Publikováno v:
Journal of Bone and Mineral Research. 14:1622-1627
Thinness (low percentage of body fat, low body mass index [BMI], or low body weight) was evaluated as a risk factor for low bone mineral density (BMD) or increased bone loss in a randomized trial of alendronate for prevention of osteoporosis in recen
Autor:
Michael R. McClung, Desmond E. Thompson, Giovanni Cizza, C. Christiansen, David J. Hosking, Nina H. Bjarnason, Pernille Ravn, R. D. Wasnich, A. J. Yates
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 84:2363-2368
To establish whether biochemical markers could be used to monitor alendronate (ALN) treatment and predict long-term response in bone mass, we used results from an ongoing, randomized trial of ALN treatment for prevention of postmenopausal osteoporosi
Autor:
Christian Rosenquist, Claus Christiansen, Peter Alexandersen, C. Fledelius, Stephan Christgau, Per Qvist, Pernille Ravn, Christian Herling, Nina H. Bjarnason
Publikováno v:
Scopus-Elsevier
The Serum CrossLapsTM One Step ELISA is a sandwich assay using two monoclonal antibodies specific for a β-aspartate form of the epitope EKAHDGGR derived from the carboxy-terminal telopeptide region of type I collagen α1-chain. Our objective was to
Autor:
David J. Hosking, M. Daley, Philip D. Ross, Pernille Ravn, Nina H. Bjarnason, Desmond E. Thompson, Giovanni Cizza, Michael R. McClung, Richard D. Wasnich, A. John Yates
Publikováno v:
Clinical Therapeutics. 20:933-944
Calcium's ability to prevent bone loss in early postmenopausal women is controversial. We used data on 394 women from the placebo group of the Early Postmenopausal Interventional Cohort study, a clinical trial of alendronate, to investigate the relat